These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15780449)

  • 1. Vaccination with recombinant HBsAg-HBIG complex in healthy adults.
    Xu DZ; Huang KL; Zhao K; Xu LF; Shi N; Yuan ZH; Wen YM
    Vaccine; 2005 Apr; 23(20):2658-64. PubMed ID: 15780449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune response for phase I clinical trial of a hepatitis B immunogenic complex therapeutic vaccine, YIC].
    Liu SA; Xu DZ; Zhang JP; Huang KL; Yao J; Xu LF; Yuan ZH; Wen YM
    Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):89-92. PubMed ID: 16494774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
    Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF
    Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients.
    Ilan Y; Nagler A; Zeira E; Adler R; Slavin S; Shouval D
    Bone Marrow Transplant; 2000 Sep; 26(6):633-8. PubMed ID: 11035369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cellular immune responses of recombinant hepatitis B (rHB) vaccine and HBsAG derived from Hansenula polymorpha cells].
    Hu ZY; He P; Zhang R; Fang X; Zhu FC; Qiu SH; Li HM; Wang H; Liang ZL; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):706-11. PubMed ID: 19031766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the immuno-effects of recombinant hepatitis B vaccination in adults].
    Zhang FM; Zhao QX; Han JH; Zhou QH; Wang MC; Miao W; Li R
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Aug; 24(8):697-9. PubMed ID: 14521791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A; Zarei S; Shokri F
    Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination.
    Bauer T; Jilg W
    Vaccine; 2006 Jan; 24(5):572-7. PubMed ID: 16171909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Humoral immunity level and factors associated with the response to the vaccine against the hepatitis B virus in health personnel of the Case-Essalud National Hospital, Arequipa September 1995-March 2002].
    Campos Nizama J
    Rev Gastroenterol Peru; 2005; 25(2):141-9. PubMed ID: 16021199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine.
    Dupont J; Altclas J; Lepetic A; Lombardo M; Vázquez V; Salgueira C; Seigelchifer M; Arndtz N; Antunez E; von Eschen K; Janowicz Z
    Vaccine; 2006 Nov; 24(49-50):7167-74. PubMed ID: 16884836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
    Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of serum IgG subclass distributions and anti-HBs response in healthy adults after hepatitis B vaccination].
    Dinç But A; Ersoy Y; Ozerol IH; Firat M
    Mikrobiyol Bul; 2005 Oct; 39(4):483-90. PubMed ID: 16544550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
    Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
    Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
    Bauer T; Günther M; Bienzle U; Neuhaus R; Jilg W
    Liver Transpl; 2007 Mar; 13(3):434-42. PubMed ID: 17318860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antibody production to hepatitis B surface antigen by interleukin 2.
    Kakumu S; Fuji A; Tahara H; Yoshioka K; Sakamoto N
    J Clin Lab Immunol; 1988 May; 26(1):25-7. PubMed ID: 3263506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.